Table 1.
Survival rate | |||||||
---|---|---|---|---|---|---|---|
Total mRNA injected (pg) | 1 day | 2 daysa | 4 days | 6 days | 15 days | 18 weeks | |
WT | N.A. | 86% (6/7) | 80% (4/5) | 80% (4/5) | 80% (4/5) | 80% (4/5) | 80% (4/5) |
TALEN1 | 300 | 88% (7/8) | 83% (5/6) | 0% (0/6) | 0% (0/6) | 0% (0/6) | 0% (0/6) |
200 | 90% (9/10) | 88% (7/8) | 13% (1/8) | 13% (1/8) | 13% (1/8) | 13% (1/8) | |
100 | 100% (9/9) | 100% (7/7) | 43% (3/7) | 29% (2/7) | 14% (1/7) | 0% (0/7) | |
50 | 100% (8/8) | 100% (6/6) | 83% (5/6) | 83% (5/6) | 67% (4/6) | 33% (2/6) | |
TALEN2 | 300 | 100% (8/8) | 33% (2/6) | 0% (0/6) | 0% (0/6) | 0% (0/6) | 0% (0/6) |
200 | 88% (7/8) | 67% (4/6) | 0% (0/6) | 0% (0/6) | 0% (0/6) | 0% (0/6) | |
100 | 100% (8/8) | 100% (6/6) | 50% (3/6) | 50% (3/6) | 0% (0/6) | 0% (0/6) | |
50 | 100% (8/8) | 83% (5/6) | 67% (4/6) | 50% (3/6) | 50% (3/6) | 50% (3/6) |
a. Two embryos from each group were harvested for DNA isolation at 2 days post‐injection. Remaining animals (N‐2) were subsequently used to determine survival rate. N = initial number of embryos injected.